Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,266,268
+$433,136 QoQ
Shares Held
10,554
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#79
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $111,447,507 across 13 Diagnostics & Research names. BLLN ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
79,816 | $40,016,549 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
61,780 | $32,523,463 | |
| 3 | DHR |
Danaher Corp /De/
|
143,844 | $27,399,405 | |
| 4 | NTRA |
Natera, Inc.
|
24,806 | $6,733,588 | |
| 5 | ILMN |
Illumina, Inc.
|
18,134 | $3,188,501 | |
| 6 | BLLN |
BillionToOne, Inc.
This page
|
10,554 | $1,266,268 | |
| 7 | LH |
Labcorp Holdings Inc.
|
280 | $78,400 | |
| 8 | WAT |
Waters Corp /De/
|
179 | $67,132 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,266,268 | 10,554 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $833,132 | 10,554 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $866,603 | 10,589 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||